Teva Pharmaceutical Finance, guaranteed by Teva Pharmaceutical Industries Ltd. (TEVA, TEVA.TV), completed a $1 billion, euro-denominated sale of seven-year bonds at 100 basis points over midswaps, said one of the banks running the deal Thursday.

The 100-basis-point spread offered on the 2.875% bonds compares with initial price guidance set between 115 and 120 basis points over midswaps.

BNP Paribas S.A., HSBC Holdings PLC, and J.P. Morgan Chase and Co., are the lead managers one the deal.

The deal has been rated A3 by Moody's Investors Service and A- by Standard & Poor's.

-By Patrick McGee and Sarka Halas, Dow Jones Newswires; 212-416-2382; patrick.mcgee@dowjones.com